Malaria is caused by a protozoan which invades human red blood cells. Malaria is one of the world's most prevalent diseases. According to the WHO, the world-wide prevalence of the disease is estimated to be 300-500 million cases and over 1 million deaths each year. Most of these victims are infants, young children. The Malaria P.f./Pan Rapid Test Cassette (Whole Blood) is a rapid test to qualitatively detect the presence of P. falciparum - specific HRP-II and four kinds of circulating plasmodium falciparum (P. falciparum (Pf), P. vivax (Pv), P. ovale (Po) and P. malariae (Pm)). The test utilizes colloidal gold conjugate to selectively detect P.f-specific and Pan-malarial antigens in whole blood.

Established in 2010, the company is a technology-based enterprise specializing in the research and development, production, sales and service of in vitro rapid diagnostic reagents. The company takes monoclonal antibody technology, molecular immunology technology, nanotechnology and microelectronics technology as its platform, accelerating the research and development of products and constantly launching rapid, sensitive, specific and accurate in vitro diagnostic series products. All product performances and indicators meet industry standards. The company attaches great importance to independent research and development, adhering to the business philosophy of "quality, reputation, service and sincerity" and the quality policy of "perfect quality, sincere service, standardized management and innovation".